UPS has entered into a definitive agreement to acquire Smartways Logistics, a healthcare-focused logistics provider operating across Australia and New Zealand, as the global logistics giant seeks to strengthen its specialised healthcare transportation capabilities in the Asia-Pacific region.
The planned acquisition will expand UPS Healthcare’s ability to handle time-critical and complex medical shipments, including medical devices, pharmaceuticals, life sciences products, clinical trial materials and radiopharmaceuticals.
Smartways operates a dedicated healthcare logistics network with more than 350 medical couriers, servicing over 1,300 hospitals daily across Australia and New Zealand. Its services include same-day ground transportation, overnight delivery, next-flight-out shipments, reverse logistics and third-party logistics solutions.
The acquisition will connect Smartways’ specialised regional capabilities with UPS’s extensive global transportation network, providing healthcare customers with improved international connectivity and end-to-end logistics solutions.
UPS Executive Vice President and Chief International, Healthcare and Supply Chain Solutions Officer Wilfredo Ramos said the deal would strengthen the company’s ability to serve customers with urgent and complex healthcare logistics requirements.
The transaction forms part of UPS’s broader strategy to expand its healthcare logistics business across Asia-Pacific. The company has been investing in regional infrastructure, including its recently opened Clark hub in the Philippines and additional healthcare cold-chain capabilities.
Healthcare logistics remains an important growth segment for UPS, with the company’s healthcare revenue reaching US$3 billion for the third consecutive quarter in Q3 2026.
The acquisition is expected to be completed in the first half of 2027, subject to customary regulatory reviews and approvals. Financial terms of the transaction have not been disclosed.
The deal will further strengthen UPS’s presence in Australasia while expanding its capabilities in the rapidly evolving global healthcare supply chain sector.
